Clear Acne Spot Treatment

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with acne vulgaris, providing therapeutic benefits in managing this dermatological condition.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of the medication. The affected area should be covered with a thin layer of the medication 1 to 3 times daily. It is recommended to initiate treatment with a single application daily, gradually increasing to 2 or 3 times daily as necessary or as directed by a physician.

In cases where excessive dryness or peeling of the skin occurs, the frequency of application should be reduced to once daily or every other day. For pediatric patients under 10 years of age, consultation with a physician is advised prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

• If irritation persists, discontinue use and consult a physician.

• Avoid unnecessary sun exposure and the use of sunscreen while using this product.

• Contact with the eyes should be avoided; in case of contact, rinse eyes thoroughly with water.

• Concurrent use with other topical acne medications may exacerbate skin dryness or irritation. Only one medication should be used at a time unless directed otherwise by a healthcare professional.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to avoid ingestion of the product. In the event of accidental swallowing, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult their healthcare provider if any irritation persists. Continuous monitoring of the patient's response to the treatment is recommended to ensure safety and efficacy.

Side Effects

Patients should be advised that the product is for external use only. In the event of persistent irritation, it is recommended that they stop using the product and consult a healthcare professional.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin when used simultaneously or immediately after the application of this product. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and treatment efficacy.

Packaging & NDC

Below are the non-prescription pack sizes of Clear Acne Spot Treatment (acne spot treatment). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 10 years of age should be evaluated by a physician prior to use. It is essential to consider individual clinical circumstances and potential risks when prescribing for this age group.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The product has not been evaluated for safety in pregnancy. Salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. The use of salicylic acid during pregnancy may pose risks, and it is advised that pregnant patients consult a healthcare provider before use. Additionally, dosage adjustments may be necessary for pregnant individuals; therefore, healthcare professionals should be consulted for guidance on appropriate dosing.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert text. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult poison control centers for additional guidance on management strategies.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that if they experience persistent irritation, they should discontinue use and consult a healthcare professional.

Healthcare providers should emphasize the necessity of avoiding unnecessary sun exposure and the importance of using sunscreen to protect the skin. Patients should also be cautioned against contact with the eyes; in the event of contact, they should rinse their eyes thoroughly with water.

Additionally, patients should be made aware that using other topical acne medications concurrently or immediately after applying this product may lead to increased dryness or irritation of the skin. If such reactions occur, they should use only one medication at a time unless otherwise directed by a healthcare provider.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to avoid unnecessary sun exposure and to use sunscreen to protect the skin. Patients are advised to avoid contact with the eyes; in the event of contact, they should rinse their eyes thoroughly with water. The concurrent use of other topical acne medications may exacerbate skin dryness or irritation, and it is recommended that only one medication be used at a time unless directed otherwise by a physician. If patients experience bothersome dryness or peeling, they should reduce the application frequency to once daily or every other day. Additionally, for children under 10 years of age, consultation with a physician is recommended.

Drug Information (PDF)

This file contains official product information for Clear Acne Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)